Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Methyl-CpG-binding domain (MBD) sequencing of 15 primary stage 4S neuroblastoma tumors


ABSTRACT: The DNA methylome of 15 primary stage 4S neuroblastoma tumors is profiled by enrichment with a methyl-CpG-binding domain (MBD) and massively parallel sequencing DNA of 15 primary stage 4S tumors is sheared (fragments of ± 200 bp), followed by MBD-based (MethylCap kit of Diagenode) enrichement, library preparation and multiplexing. Both input DNA and captured DNA were sequenced paired-end on Illumina Hiseq2000

ORGANISM(S): Homo sapiens

SUBMITTER: Anneleen Decock 

PROVIDER: E-GEOD-69268 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications


Accurate assessment of neuroblastoma outcome prediction remains challenging. Therefore, this study aims at establishing novel prognostic tumor DNA methylation biomarkers. In total, 396 low- and high-risk primary tumors were analyzed, of which 87 were profiled using methyl-CpG-binding domain (MBD) sequencing for differential methylation analysis between prognostic patient groups. Subsequently, methylation-specific PCR (MSP) assays were developed for 78 top-ranking differentially methylated region  ...[more]

Similar Datasets

2015-11-19 | E-GEOD-69243 | biostudies-arrayexpress
2015-12-15 | GSE69268 | GEO
2009-05-05 | E-TABM-119 | biostudies-arrayexpress
| PRJNA65173 | ENA
| PRJNA65175 | ENA
2009-10-01 | GSE17540 | GEO
2014-05-20 | E-GEOD-50935 | biostudies-arrayexpress
2014-06-17 | E-GEOD-58549 | biostudies-arrayexpress
| PRJNA65179 | ENA
| PRJNA65181 | ENA